G.Barekat Pharm (XTEH:BRKT1) Other Income (Minority Interest) : IRR-1,936,320 Mil (TTM As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. G.Barekat Pharm's Other Income (Minority Interest) for the six months ended in Mar. 2017 was IRR-1,936,320 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2017 was IRR-1,936,320 Mil.

G.Barekat Pharm Other Income (Minority Interest) Historical Data

The historical data trend for G.Barekat Pharm's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Other Income (Minority Interest) Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Other Income (Minority Interest)

-1,626,187.00

-1,936,320.00

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Other Income (Minority Interest)	-1,626,187.00	-1,936,320.00

G.Barekat Pharm Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2017 was IRR-1,936,320 Mil.

G.Barekat Pharm (XTEH:BRKT1) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Other Income (Minority Interest)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines